Robert M. Long, Co-founder and CEO
Robert “Bob” Long is the Co-Founder and CEO of GlychoCheck and Microvascular Health Solutions (MVHS). He is an experienced business executive, leader and entrepreneur with a proven history in strategic planning, accountability and results-driven success. As Co-Founder and CEO of GlycoCheck and MVHS, Bob directs commercial operations and is committed to developing an organization that identifies medical device companies and nutritional therapies focused on reducing healthcare costs. Bob and Co-Founder Hans Vink have assembled a talented team in GlycoCheck. GlycoCheck is dedicated to educating research institutions, clinicians and consumers, as well as developing and providing cutting-edge microvascular testing systems and nutritional supplements to support the human microvascular system. Bob has previously built several dynamic and profitable companies and teams, both domestically and internationally, as he has worked with key investors to maintain accountability and regular reporting on benchmarks. Bob is a driven executive, emphasizing achievement, focus, and direction spanning from product development to sales and marketing, through operations. In every business endeavor, Bob cuts through to clearly and concisely articulate the benefits of the organization’s offerings to its intended market. One of Bob’s greatest talents is his ability to motivate team members to success, which is evident in the results he has consistently delivered for his companies and their stakeholders.
Hans Vink, PhD, Co-founder and Chief Science Officer
Dr. Hans Vink, PhD is the Co-Founder and Chief Science Officer of GlycoCheck Microvascular Health Solutions. A biomedical researcher and a pioneer in the study of the endothelial glycocalyx, Dr. Hans Vink developed the GlycoCheck technology system that allows the clinical assessment of the glycocalyx. He is often sought out to lecture at universities and medical institutions around the world due to his expertise in the science of glycocalyx observation and his passion for sharing his extensive understanding of the vascular system. Hans earned a PhD in Physics from the University of Amsterdam in 1994, where he began his study of the glycocalyx. He continued his research as a postdoctoral fellow at the University of Virginia, and returned to Amsterdam in 1997 to continue his work. He was awarded a Research Fellowship from the Royal Netherlands Academy of Arts and Sciences for his study of the glycocalyx from 2000 through 2005. In 2005 he became an Established Investigator of the Netherlands Heart Foundation. In 2006 he joined the department of Physiology at Maastricht University, where he continues glycocalyx research as a Principle Investigator within the Cardiovascular Research Institute Maastricht (CARIM). He has authored or contributed on more than 75 scholarly papers and reviews and he has been awarded several grants to further the study of the glycocalyx and its importance to human health.